As the world began to open up for travel and face-to-face meetings in person, 2022 brought growth, networking opportunities, customer collaboration, and inspiring stories. Not only were we able to create new partnerships and integrate more systems onto the MDClone ADAMS Platform, our team was able to travel the globe to meet leaders from health systems, life science organizations, and federal entities in Israel, North America, and beyond.
Here are our top 10 memorable MDClone moments of 2022.
01.
Raised $63M in Funding to Fuel Global Growth
In March, we welcomed two new investment partners to MDClone: Viola Growth and Warburg Pincus – amounting Series C funding initiatives to $63 million. With this financial support, we were able to accelerate the expansion of our software’s technology, the regional markets it is being implemented in, as well as expansion into a new vertical market: Life Sciences.
READ MORE →
Growth in 2022 expanded to our team of MDClone employees across Canada, the United States, and Israel, as well. With 68 new team members in 2022, we brought on more hands to do the work we set out to do from the very beginning – to make a difference in healthcare through big data. The leadership team has some exciting things planned to make happen in the coming year, and we can’t wait to see where it takes our company as a whole and the software our customers use to reach innovative goals.
Join the team →
“[MDClone] has shown great progress in the past year and an even bigger vision that we believe can transform the way doctors around the world can treat patients and improve care.””
02.
Won “Best Healthcare Big Data Platform”… Again
The month of May brought news that we had won MedTech Breakthrough’s Best Healthcare Big Data Platform award for the second consecutive year. It was an honor to be selected for this award that recognizes the top companies, technologies, and products in the global health and medical technology market.
With our unique platform, users are enabled to view streamlined data from any patient-oriented source – structured or unstructured – including natural language processing (NLP) data points from clinical, claims, genomics, social events, and more. But what makes it special is that ADAMS allows for the ingestion of continuous data feeds of information. This means any new data source can be added to create new events, layer additional information, and revise hypotheses, all without SQL programming skills which are typically required when using other data analytics platforms.
READ MORE →
03.
Celebrated Diversity
Our Vice President of Human Resources at MDClone, Tehlia Shami-Kurz, was able to attend Israeli organization Power in Diversity’s event alongside other startups at Global Diversity Day at the end of May. It was at the event MDClone was awarded a certificate of appreciation for Diversity, Equity, and Inclusion (DEI) in the Israeli Tech Industry.
Being recognized for our initiatives not only shined a light on our extensive female representation in high-tech (which is 50% within the company as a whole, and 48% within R&D), but our values as a company, too.
VIEW PHOTOS →
“At MDClone we walk the walk, and not just talk the talk. We believe in being open to all. We therefore hire great motivated people who share our values. Those who are passionate about making an impact on people’s lives.””
04.
Partnered with Canada’s MCI Onehealth Technologies, Inc.
With a big goal of breaking into a new opportunity of third-party access to various synthetic data lakes, partnering with MCI Onehealth was an exciting accomplishment.
Using the MDClone ADAMS Platform analytics tools and synthetic data capabilities, clinicians, researchers, and healthcare professionals can explore healthcare data efficiently to accelerate real-world evidence processes. With synthetic data capabilities at the forefront, users leverage self-service tools to access, analyze, and share information without privacy concerns. Additionally, the real-time identification and extraction of information about a specific population of interest allows users at healthcare systems to overcome common barriers that slow clinical data projects’ progress. This solution has been shown to reduce hospitalizations and prevent unnecessary morbidity and mortality in some use cases.
MCI’s audience for health insights continues to grow in Canada and will further benefit from access to MDClone’s global roster of top-tier health system and pharma relationships. The collaboration with MDClone immediately gives MCI entry into the clinical insights and analytics sectors in the U.S. and Israel, including headquarter-level decision-makers of global pharma and life science leaders.
READ MORE →
05.
Received Top Scores from KLAS Research
You could imagine our excitement when we received the feedback from KLAS Research informing us of top scores from 10 individuals representing 7 unique hospitals/health organizations. MDClone received nearly all A and B ratings from customer feedback through the unbiased, third-party research company. Having these high marks not only validates that MDClone is aligned with our customers and partners, but it also proves the software we create is needed, wanted, and being recognized as an innovative addition to healthcare systems.
“I would tell others thinking about using the MDClone solution to start early. I think it will be a system installed in every big hospital that wants to be data driven.””
KLAS’ Emerging Technology Spotlight Reports help healthcare organizations separate fact from fiction in emerging healthcare areas. Each spotlight focuses on a single technology or company with the goal to validate early customer experiences and how innovative companies are solving healthcare problems. Sections of the report include overall customer satisfaction scores, key performance indicators, adoption of key functionality, and more.
READ the report →
06.
Launched the First-Ever Synthetic Data Platform for Life Science RWE Project Collaboration
Adding to the suite of solutions MDClone provides its users with, the Connect Platform was launched. In an effort to create an innovative workspace which enables cross-organization collaboration, the Connect platform allows dynamic access to more than 50+ million synthetic patient records between the US, Canada, and Israel.
The new platform not only keeps patient privacy at the forefront, it is excelling research forward faster than ever before. As the industry leader in synthetic data, combined with our forward-thinking approaches to self-service data exploration, we offer a unique solution to get usable, granular data to power RWE projects in record time.
Uniting life sciences, tech companies, and other third-party organizations with leading health systems worldwide allows users to work directly at the source to explore, iterate, and ultimately land on transformative information.
Learn More →
07.
Continued Academic Research Partnership with Jefferson Health & Thomas Jefferson University
Thomas Jefferson University and Jefferson Health partnered with us in November of this year to continue working together to accelerate academic research. The ADAMS platform helps researchers reduce the friction points from formulation questions to actually producing results. Like many organizations, there are siloed systems, long timelines, and complex data models in place that put a pause on valuable answers. With MDClone’s software in place, Jefferson will create a more frictionless ecosystem for researchers to access clinical data – driving quicker timelines from idea to impact.
Read More →
08.
Events, Events, and More In-Person Events
We were proud to be a part of so many industry events this year. MDClone was a premier sponsor of AMIA and Reuters Total Health, as well as a platinum sponsor of the The Ottawa Hospital Quality & Patient Safety conference. We traveled the globe this year, with speaking opportunities, trade shows, and meetings in Chicago, Washington D.C., Philadelphia, Canada, Israel, and beyond. It was igniting to visit with leaders in healthcare and life sciences face to face, and we can’t wait to see what 2023 will bring.
In June, we were able to participate in Innovation Week in Tel Aviv, Israel. Joining together with hundreds of healthcare leaders across the health system, federal, and life science space, we were able to share ideas, stories, and expertise with the goal of accelerate innovation in healthcare.
We want to give a special shoutout to our outstanding customers and advocates who joined us this year at our booth and on stage. It is because of your support we are able to progress the efforts of big data analysis through the ADAMS platform to a larger network of innovative organizations.
09.
Played a Critical Role in Helping to Prevent Veteran Suicide
MDClone’s integration with the VHA’s initiatives to end veteran suicide has seen strides since our partnership began in 2020. With the use of synthetic data accurately mimicking real-world conditions, treatment and engaging veterans at risk can be identified as early as possible.
In addition to the VHA’s use of synthetic data for predictive modeling and quality improvement, Mission Daybreak began in an effort to help reduce veteran suicide through real-time innovation efforts. With its first phase completed, the mission is now rolling out into phase two and three with synthetic data analysis at its core.
Learn more →
10.
Orchestrated the Launch of the ADAMS Center at Sheba Medical Center
Last fall, we began creating a new endeavor with Sheba Medical Center to launch the first-ever ADAMS Center within Sheba Medical Center. The recently launched ADAMS Center will boast an interdisciplinary team of researchers and clinicians who will apply the ADAMS platform to a variety of clinical, operational, and financial data-driven projects. The methodology will streamline insight-to-action across the full spectrum of the health systems departments.
Sheba is the first hospital in Israel to deploy the system, setting both a national and international precedent for excellence in healthcare via innovation. We are excited to launch this system on a global level in 2023.
